血栓抽吸导管联合冠脉内注射替罗非班对急性心梗患者PCI中的疗效及安全性

血栓抽吸导管联合冠脉内注射替罗非班对急性心梗患者PCI
中的疗效及安全性
韩羽
【期刊名称】《心血管康复医学杂志》
【年(卷),期】2018(027)001
【摘要】目的:探讨血栓抽吸导管联合冠脉内注射替罗非班对急性心肌梗死患者经皮冠脉介入(PCI)术的疗效及安全性. 方法:选择124例PCI治疗的急性心肌梗死患者, 随机分为血栓抽吸组(62例, 采用单纯血栓抽吸导管行PCI), 联合治疗组(62例, 采用血栓抽吸导管联合冠脉内注射替罗非班进行PCI治疗), 对比两组临床疗效、不良事件发生情况. 结果:PCI治疗后, 与血栓抽吸组比较, 联合治疗组左室射血分数[术后30d:(51. 04±6. 66)％比(62. 87±8. 12)％]明显提高, 左室舒张末期内径[术后30d:(53. 78±5. 19)mm比(43. 89±5. 24)mm]和左室收缩末期内径[术后
30d:(42. 18±4. 09)mm比(30. 85±4. 98)mm]明显减小; 肌酸激酶[(161. 85±3.
74)U/L比(132. 54±3. 85)U/L]、肌酸激酶同工酶[(32. 58±1. 30)U/L比(29.
45±1. 24)U/L]、乳酸脱氢酶[(304. 58±3. 14)U/L比(241. 95±2. 14)U/L]和天冬氨酸氨基转移酶[(204. 54±3. 57)U/L比(165. 47±2. 48)U/L]水平明显降低; 手术成功率(82. 26％比100％)、ST段回落率(74. 19％比88. 91％)均明显提高(P＜0. 05或＜0. 01), 两组大出血、心脏事件发生率无显著性差异(P均＞0. 05). 结论:急性心肌梗死患者PCI手术中应用血栓抽吸导管联合冠脉内注射替罗非班可显著提高手术成功率、ST段回落率, 改善心功能及心脏结构, 且具有良好的安全
性.%Objective: To explore therapeutic effect of thrombus aspiration catheter combined intracoronary tirofiban injection on patients with acute
myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) and its safety. Methods: A total of 124 AMI patients undergoing PCI were selected, randomly divided into thrombus aspiration group (n=62, received PCI with pure thrombus aspiration catheter) and combined treatment group (n=62, received PCI with thrombus aspiration catheter combined intracoronary tirofiban injection). Therapeutic effect and incidence of adverse events were compared between two groups. Results: Compared with thrombus aspiration group after PCI, there was significant rise in left ventricular eje ction fraction [30d after PCI: (51. 04±6.
66) ％vs. (62. 87±8. 12) ％], and significant reductions in left ventricular end-diastolic dimension [30d after PCI: (53. 78±5. 19) mm vs. (43. 89±5. 24) mm]and left ventricular end-systolic dimension [30d after PCI: (42. 18±4. 09) mm vs. (30. 85±4. 98) mm]; significant reductions in levels of creatine kinase [CK, (161. 85±3. 74) U/L vs. (132. 54±3. 85) U/L], CK isoenzyme MB [(32. 58±1. 30) U/L vs. (29. 45±1. 24) U/L], lactate dehydrogenase [(304.
58±3. 14) U/L vs. (241. 95±2. 14) U/L]and aspartate transaminase [(204.
54±3. 57) U/L vs. (165. 47±2. 48) U/L], and significant rise in success rate of PCI (82. 26％ vs. 100％) and ST regression rate (74. 19％ vs. 88. 91％) in combined treatment group, P＜0. 05 or＜0. 01. There were no significant difference in incidence rates of massive hemorrhage and cardiac events between two groups (P＞0. 05 both). Conclusion: Thrombus aspiration catheter combined intracoronary tirofiban injection during PCI can significantly increase success rate of PCI and ST regression rate, improve cardiac function and cardiac structure with good safety in AMI patients.
【总页数】4页(P58-61)
【作者】韩羽
【作者单位】黑龙江省大庆龙南医院心内科, 黑龙江大庆 163457
【正文语种】中文
【中图分类】R542.22
【相关文献】
1.直接冠脉内注射替罗非班在急性心肌梗死患者急诊PCI中治疗疗效的研究 [J], 尤威;叶飞;陈绍良;田乃亮;张俊杰;徐兢
2.老年急性心梗并糖尿病患者替罗非班冠脉内注射的临床效果分析 [J], 吕兴旺
3.介入治疗联合冠脉内注射替罗非班对急性心肌梗死患者疗效及安全性的影响 [J], 王宗帅
4.抽吸导管联合替罗非班冠脉内注射在急性ST段抬高型心梗中的应用 [J], 张立博;苏仁芳;陈德超;关丽卿;周杰良;吴咏豪;付熠;宾冬梅
5.早期冠脉注射替罗非班在急性心梗患者中的治疗效果分析 [J], 罗珲;孙俊生;郑艳娥;姚丁烨;吴周松;邓翠雯
因版权原因，仅展示原文概要，查看原文内容请购买。